reference/7192570

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7192570

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	4854
issn	1527-7755 0732-183X
issueIdentifier	30
pageRange	4848-4854
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	4848
bibliographicCitation	Govindan R, Crowley J, Schwartzberg L, Kennedy P, Williams C, Ekstrand B, Sandler A, Jaunakais D, Bolejack V, Ghalie R. Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies. J Clin Oncol. 2006 Oct 20;24(30):4848–54. doi: 10.1200/jco.2006.07.7404. PMID: 17050870.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c2a0bc30be23f29713ec00c6d4998df http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6882-8179 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61385b448d228c85371fdbf8f0f1b9d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_772d62bd53d0532b9f31ea6a8da28770 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25e1d3d5bd39d25c57c4a835d4932572 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b45cd01edc3dfd5f5cb4a4cb0837894 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_243ca4b729008257349600f8b0f948e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9033f0b821af2c791aade932a80b8862 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eccc6187008231a130f692ca8c009d44 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bdeed57a0653924d1265c98d007491c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f03cc2255f601e6a35f3b112e5a2d6fe
date	2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2006.07.7404 https://pubmed.ncbi.nlm.nih.gov/17050870
isPartOf	https://portal.issn.org/resource/ISSN/1527-7755 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase II Trial of Bexarotene Capsules in Patients With Advanced Non–Small-Cell Lung Cancer After Failure of Two or More Previous Therapies
discusses	http://id.nlm.nih.gov/mesh/M0025302 http://id.nlm.nih.gov/mesh/M0003316 http://id.nlm.nih.gov/mesh/M0250478 http://id.nlm.nih.gov/mesh/M0021234
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016588Q000008 http://id.nlm.nih.gov/mesh/D013764Q000008 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D016588Q000009 http://id.nlm.nih.gov/mesh/D013764Q000009 http://id.nlm.nih.gov/mesh/D002289Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002214 http://id.nlm.nih.gov/mesh/D000077610 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D010996Q000209 http://id.nlm.nih.gov/mesh/D002289Q000150 http://id.nlm.nih.gov/mesh/D015228Q000139 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008175Q000150 http://id.nlm.nih.gov/mesh/D005076Q000139 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D016019 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82146 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5819 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9683 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8900 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128675752 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742115

Total number of triples: 70.